Related Experiment Video

Updated: Aug 7, 2026

Use of a Piglet Model for the Study of Anesthetic-induced Developmental Neurotoxicity (AIDN): A Translational Neuroscience Approach
06:38

Use of a Piglet Model for the Study of Anesthetic-induced Developmental Neurotoxicity (AIDN): A Translational Neuroscience Approach

Published on: June 11, 2017

The pharmacokinetics of thiopental in pediatric surgical patients

S Sorbo, R J Hudson, J C Loomis

    Anesthesiology
    |December 1, 1984
    PubMed

    Insights

    Pediatric patients exhibit significantly higher thiopental clearance and shorter elimination half-lives compared to adults, primarily due to increased hepatic clearance. This suggests faster recovery times in children after thiopental administration.

    Area of Science:

    • Pharmacology
    • Pediatric Anesthesiology

    Background:

    • Thiopental is a common anesthetic agent used in pediatric surgery.
    • Understanding its pharmacokinetics in children is crucial for safe and effective anesthesia.
    • Previous studies have established thiopental pharmacokinetics in adults, but data in pediatric populations are less comprehensive.

    Purpose of the Study:

    • To determine the pharmacokinetics and protein binding of thiopental in pediatric surgical patients.
    • To compare these pharmacokinetic parameters with those previously established in adult patients.
    • To investigate the relationship between age and thiopental clearance/elimination half-time in children.

    Main Methods:

    • A single intravenous bolus of thiopental was administered to 24 pediatric patients (5 months to 13 years).
    • Pharmacokinetic parameters including clearance and elimination half-time were calculated.
    • Serum protein binding of thiopental was assessed.
    • Data were compared to a cohort of 11 adult patients.

    Main Results:

    • Pediatric patients showed significantly higher total drug clearance (6.6 mL/kg/min) compared to adults (3.1 mL/kg/min).
    • The elimination half-time was significantly shorter in pediatric patients (6.1 hours) than in adults (12 hours).
    • Distribution kinetics and protein binding were similar between pediatric and adult groups.

    Conclusions:

    • Pediatric patients have a greater hepatic clearance of thiopental, leading to a shorter elimination half-time.
    • Faster clearance in children suggests potentially more rapid recovery from anesthesia compared to adults.
    • Age-related decrease in clearance was observed in pediatric patients, indicating maturation of hepatic metabolism.

    More Related Videos

    Anesthesia and Intubation of Preadolescent Mouse Pups for Cardiothoracic Surgery09:47

    Anesthesia and Intubation of Preadolescent Mouse Pups for Cardiothoracic Surgery

    Published on: June 2, 2022

    Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs08:58

    Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs

    Published on: October 31, 2025

    Related Concept Videos

    Parenteral Anesthetics: Overview01:24

    Parenteral Anesthetics: Overview

    Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
    Drug Dosing: Infants and Children01:29

    Drug Dosing: Infants and Children

    Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

    Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
    Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

    Pharmacokinetics in Pediatric Patients: Drug Distribution

    Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
    Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

    Pharmacokinetics in Pediatric Patients: Drug Metabolism

    In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
    Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

    Pharmacokinetics in Pediatric Patients: Drug Excretion

    In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...